Safety Alerts & Recalls
The FDA is warning healthcare providers about the risk for dosing errors with Zerbaxa (ceftolozane and tazobactam; Cubist) due to confusion of the strength displayed on the vial and carton labeling.
The Food and Drug Administration (FDA) has issued a warning to healthcare providers on the purchasing of counterfeit, unapproved, or otherwise unsafe prescription drugs from unauthorized or unlicensed distributors.
The Food and Drug Administration (FDA) announced that Teva Parenteral Medicines is voluntarily recalling eight lots of Adrucil (fluorouracil injection) due to the potential presence of visible foreign particulate matter.
The Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) announced that Sanofi Pasteur is voluntarily recalling three lots of its Fluzone Quadrivalent (quadrivalent inactivated "split virus" influenza vaccine [Types A and B]) due to potency issues.
The Food and Drug Administration (FDA) is warning consumers not to use or buy the following tainted supplements marketed for weight loss and sexual enhancement:
The Food and Drug Administration (FDA) has issued a proposed rule requesting additional scientific data to support the safety and efficacy of certain ingredients in antiseptics used in healthcare and marketed under the over-the-counter drug monograph.
The Food and Drug Administration (FDA) has issued warning letters to fourteen manufacturers of dietary supplements due to the listing of 1,3-Dimethylbutylamine (also known as DMBA, 2-amino-4-methylpentane, AMP citrate, and 4-methyl-2-pentanamine) on the product label.
Mylan announced a voluntary recall of multiple injectable products due to the potential presence of visible foreign particulate matter.
The Food and Drug Administration (FDA) has issued warning letters to five manufacturers of dietary supplements due to the listing of R-beta-methylphenethylamine (also known as Beta-methylphenethylamine, βMePEA, or BMPEA) on the product label.
The Food and Drug Administration (FDA) has issued a Class 1 recall for the Ebola Virus One-Step Test Kits (LuSys Laboratories). This test kit has not been cleared or approved by the FDA for in vitro diagnostic detection of Ebola Virus infection.
- McDonald's and the Microbiome: What Effect Does Junk Food Have on Gut Bacteria?
- When the Doctor is Depressed: One Clinician Tells His Story
- Most Distinctive Causes of Death Mapped by U.S. State
- Spice + Statin Likely Culprit in Patient with Acute Hepatitis
- First Non-Surgical Tx for "Double Chin" Gains FDA Approval
- Antiviral May Tighten Blood-Brain Barrier Against Pathogens
- Better Outcomes for HIV Patients Who Start Treatment Early, Says Study
- DOD: Live Anthrax Accidentally Sent to Nine States, South Korea
- New OTC Lightweight Wearable Launched for Chronic Pain Relief
- FDA: Beware of Embolization With Dermal Fillers